Noguchi A, Imoto H, Yoshida H, Asano S, Unno M, Shinya F. Malignant rhabdoid tumours of the small intestine with multiple organ involvement: Case report.
Int J Surg Case Rep 2021;
79:386-389. [PMID:
33517209 PMCID:
PMC7847821 DOI:
10.1016/j.ijscr.2021.01.081]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2020] [Revised: 01/18/2021] [Accepted: 01/18/2021] [Indexed: 11/16/2022] Open
Abstract
Malignant rhabdoid tumours (MRTs) are aggressive disease with poor prognosis.
Small intestine is the rare site of MRTs and curative resection is important.
Effective systemic therapies are needed for MRTs with multiple organ involvement.
Clinical trials are ongoing to develop new therapies for MRTs.
Introduction and importance
Malignant rhabdoid tumours (MRTs) were first described as an infrequent variant of Wilms’ tumour and have been reported in several organs. The small intestine is a rare site for MRTs.
Case presentation
A 70-year-old man presented with appetite loss and melena. Haemorrhagic small intestinal tumours, swollen mesenteric and paraaortic lymph nodes, a tumour in the left kidney, and multiple tumours in the lung were found. He underwent partial resection of two haemorrhagic small intestinal tumours classified as MRTs based on the results of a pathological examination. However, melena appeared again on postoperative day 6. We performed another operation and resected approximately 180 cm of the small intestine that contained multiple tumours. All lesions were classified as MRTs. Unfortunately, melena appeared again 4 days after the second operation. He did not want invasive therapy and died from massive melena 2 months after the initial surgery.
Clinical discussion
MRTs of the small intestine are uncommon and have an extremely poor prognosis. Although curative resection is an important treatment, cases of metastasis at diagnosis and postoperative early recurrence have been observed, as was the case for the patient described herein. In these cases, effective systemic therapy is necessary. Recently, tumour suppressor genes were shown to be involved in the occurrence of MRT, and new therapies for MRT have been studied.
Conclusion
We herein conclude effective systemic therapy is necessary for MRTs with multiple organ involvement. The development of new drugs for this disease is ongoing.
Collapse